「忌」の検索結果
64件：56～60件目を表示
もしかして
-
······························································································17 2．禁忌内容とその理由····························································································...
https://www.senju.co.jp/system/files/2021-07/20210705_MK_IF.pdf -
······························································································18 2．禁忌内容とその理由····························································································...
https://www.senju.co.jp/system/files/2022-03/20220330_MKLA_IF_0.PDF -
······························································································22 2．禁忌内容とその理由····························································································...
https://www.senju.co.jp/system/files/2024-01/Mikeluna_IF_20240111.pdf -
······························································································18 2．禁忌内容とその理由····························································································...
https://www.senju.co.jp/system/files/2022-03/20220330_MKLA_IF.PDF -
ける当該副作用発現状況を把握し、必要に応じて安全対策を実施す るため。 リスク最小化活動の内容及びその選択理由： 【内容】 ・通常のリスク最小化活動として、電子化された添付文書（電子添文）の「2. 禁忌」 「8. 重要な基本的注意」 「11.1 重大な副作用」の項及び患者向医薬品ガイドに記載し注意 喚起する。 ・追加のリスク最小化活動として、以下を実施する。 1. 患者向け資材（アイザベイ硝子体内...
https://www.senju.co.jp/system/files/rmp_document/2026-01/IZV_202601_02_RMP.pdf